计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| D140839-1g |
1g |
现货 ![]() |
| |
| D140839-5g |
5g |
现货 ![]() |
| |
| D140839-25g |
25g |
现货 ![]() |
| |
| D140839-100g |
100g |
现货 ![]() |
|
| 别名 | 双氢青蒿素 |
|---|---|
| 英文别名 | β-Dihydroartemisinin | (3R,5aS,6R,8aS,9R,12R,12aR)-Decahydro-10-hydroxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin | Alaxin | Cotecxin | Cotexin | DHQHS 2 | Dihydroartemisinine | Dihydroqinghaosu. |
| 规格或纯度 | Moligand™, ≥98% |
| 英文名称 | Dihydroartemisinin |
| 生化机理 | 诱导细胞周期停滞并抑制癌细胞中的细胞迁移。通过运铁蛋白受体1消耗细胞铁。抗疟和抗肿瘤剂。口服具有活性,在体内和体外具有活性。 |
| 应用 | 抗疟药;抗银屑病;抗炎剂。 |
| 储存温度 | 2-8°C储存,充氩 |
| 运输条件 | 冰袋运输 |
| 备注 | 如果有可能,您尽量在使用的当天配置溶液,并在当天使用完它。但是,如果您需要预先配制储备溶液,我们建议您将溶液等份保存在-20°C的密封小瓶中。通常,它们最多可以使用一个月。在使用前和打开样品瓶之前,我们建议您让您的产品在室温下平衡至少1小时。需要更多关于溶解度,用法和处理的建议吗?请访问我们的常见问题(FAQ)页面以获取更多详细信息。 |
| 产品介绍 |
无臭,味苦。在氯仿中易溶,在丙酮中溶解,在甲醇或乙醇中略溶,在水中几乎不溶。抗疟药;抗银屑病;抗炎剂。 Dihydro Artemisinin is an active antimalarial metabolite. Dihydro Artemisinin is also the main metabolite of Artemisinin, Arteether, Artemether, Artesunate. |
| 纯度 | ≥98% |
| PubChem SID | 504762275 |
|---|---|
| 分子类型 | 小分子 |
| IIUPAC Name | (1R,4S,5R,8S,9R,10S,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-ol |
| INCHI | 1S/C15H24O5/c1-8-4-5-11-9(2)12(16)17-13-15(11)10(8)6-7-14(3,18-13)19-20-15/h8-13,16H,4-7H2,1-3H3/t8-,9-,10+,11+,12+,13-,14-,15-/m1/s1 |
| InChi Key | BJDCWCLMFKKGEE-ISOSDAIHSA-N |
| Smiles | CC1CCC2C(C(OC3C24C1CCC(O3)(OO4)C)O)C |
| Isomeric SMILES | C[C@@H]1CC[C@H]2[C@H]([C@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)O)C |
| 关联CAS | 81496-82-4 |
| 分子量 | 284.35 |
| Reaxy-Rn | 25123268 |
| Reaxys-RN link address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=25123268&ln= |
| 溶解性 | Soluble in DMSO (57 mg/ml) at 25 °C, ethanol (14 mg/ml) at 25 °C, and water (<1 mg/ml) at 25 °C. |
|---|---|
| 密度 | 1.24 |
| 敏感性 | 对空气、热敏感 |
| 熔点 | 145-150℃ |
| 分子量 | 284.350 g/mol |
| XLogP3 | 2.500 |
| 氢键供体数Hydrogen Bond Donor Count | 1 |
| 氢键受体数Hydrogen Bond Acceptor Count | 5 |
| 可旋转键计数Rotatable Bond Count | 0 |
| 精确质量Exact Mass | 284.162 Da |
| 单同位素质量Monoisotopic Mass | 284.162 Da |
| 拓扑极表面积Topological Polar Surface Area | 57.200 Ų |
| 重原子数Heavy Atom Count | 20 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 415.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 8 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| RTECS | KD4165550 |
|---|---|
| Merck Index | 817 |
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | D140839 | |
| 分析证书 | D140839 | |
| 分析证书 | D140839 | |
| 分析证书 | D140839 | |
| 分析证书 | D140839 | |
| 分析证书 | D140839 | |
| 分析证书 | D140839 | |
| 分析证书 | D140839 | |
| 分析证书 | D140839 | |
| 分析证书 | D140839 | |
| 分析证书 | D140839 | |
| 分析证书 | D140839 | |
| 分析证书 | D140839 | |
| 分析证书 | D140839 | |
| 分析证书 | D140839 | |
| 分析证书 | D140839 | |
| 分析证书 | D140839 | |
| 分析证书 | D140839 | |
| 分析证书 | D140839 | |
| 分析证书 | D140839 | |
| 分析证书 | D140839 | |
| 分析证书 | D140839 | |
| 分析证书 | D140839 |
| 1. (2015) All chapters. Guidelines for the Treatment of Malaria, [PMID:26020088] |
| 2. Bang S et al.. (2021) Activation of GPR37 in macrophages confers protection against infection-induced sepsis and pain-like behaviour in mice.. Nat Commun, 12 (1704). [PMID:33731716] |
| 3. Jingjing Zhen, Faguang Ma, Rongxin Lin, Ming Yan, Yilin Wu. (2024) Porous MOFs-based self-assembled membrane with specific rebinding nanocages for selective recognition and separation at molecular level. DESALINATION, 572 (117124). [10.1016/j.desal.2023.117124] |
| 4. Weibai Bian, Ruixuan Zhang, Xiaohui Chen, Chuanxun Zhang, Minjia Meng. (2023) Three-Dimensional Porous PVDF Foam Imprinted Membranes with High Flux and Selectivity toward Artemisinin/Artemether. MOLECULES, 28 (21): (7452). [PMID:37959871] [10.3390/molecules28217452] |
| 5. Kaicheng Zhang, Rongxin Lin, Ming Yan, Yilin Wu. (2023) Click-chemistry synergic MXene-functionalized flexible skeleton membranes for accurate recognition and separation. JOURNAL OF COLLOID AND INTERFACE SCIENCE, 652 (2005). [PMID:37690308] [10.1016/j.jcis.2023.09.028] |
| 6. Jiantang Liang, Lei Li, Hailong Tian, Zhihan Wang, Guowen Liu, Xirui Duan, Meiwen Guo, Jiaqi Liu, Wei Zhang, Edouard C. Nice, Canhua Huang, Weifeng He, Haiyuan Zhang, Qifu Li. (2023) Drug Repurposing-Based Brain-Targeting Self-Assembly Nanoplatform Using Enhanced Ferroptosis against Glioblastoma. Small, (2303073). [PMID:37460404] [10.1002/smll.202303073] |
| 7. Qi Duan, Junxia Wu. (2023) Dihydroartemisinin ameliorates cerebral I/R injury in rats via regulating VWF and autophagy-mediated SIRT1/FOXO1 pathway. Open Medicine, 18 (1): [PMID:37415610] [10.1515/med-2023-0698] |
| 8. Jing Yan, Faguang Ma, Yilin Wu. (2023) Permselective and transparent wooden membrane with artemisinin-imprinted nanocages based on a MOFs@C3N4 self-assembly design. Materials Today Nano, 23 (100369). [10.1016/j.mtnano.2023.100369] |
| 9. Jingsong Lu, Jing Yu, Wensheng Xie, Zhenhu Guo, Xiaohan Gao, Ying Li, Ziqing Zhang, Zeping Jin, Abdul Fahad, Shenglei Che, Lingyun Zhao, Yen Wei. (2023) Acidity-Triggered Charge-Convertible Conjugated Polymer for Dihydroartemisinin Delivery and Tumor-Specific Chemo-Photothermal Therapy. ACS Applied Bio Materials, 6 (6): (2303–2313). [PMID:37190932] [10.1021/acsabm.3c00169] |
| 10. Shi Hanqiang, Xiong Lie, Yan Guang, Du Shuqin, Liu Jie, Shi Yanbo. (2023) Susceptibility of cervical cancer to dihydroartemisinin-induced ferritinophagy-dependent ferroptosis. Frontiers in Molecular Biosciences, 10 [PMID:37065442] [10.3389/fmolb.2023.1156062] |
| 11. Jing Yan, Kaicheng Zhang, Faguang Ma, Hang Cui, Yilin Wu. (2023) Scalable basswood-based PDA/GO-embedded self-assembly membrane within multilayered artemisinin-imprinted nanocage for high-selectivity cascading adsorption and transport. CHEMICAL ENGINEERING JOURNAL, 462 (142277). [10.1016/j.cej.2023.142277] |
| 12. Wang Huai-Song, Xia Xingya, Wang Yingming, Lyu Weiping, Sang Mangmang, Gu Congcong, Liu Wenyuan, Zheng Feng. (2021) Anti-cancer adjuvant drug screening via epithelial-mesenchymal transition-related aptamer probe. ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 413 (28): (6951-6962). [PMID:34676432] [10.1007/s00216-021-03669-x] |
| 13. Longkai Yang, Qiu Xiong, Yanbo Li, Peng Gao, Ben Xu, Hong Lin, Xin Li, Tsutomu Miyasaka. (2021) Artemisinin-passivated mixed-cation perovskite films for durable flexible perovskite solar cells with over 21% efficiency. Journal of Materials Chemistry A, 9 (3): (1574-1582). [10.1039/D0TA10717D] |
| 14. Yilin Wu, Wendong Xing, Minjia Meng, Jian Lu, Faguang Ma, Jia Gao, Xinyu Lin, Chao Yu. (2020) Multiple-functional molecularly imprinted nanocomposite membranes for high-efficiency selective separation applications: An imitated core-shell TiO2@PDA-based MIMs design. COMPOSITES PART B-ENGINEERING, 198 (108123). [10.1016/j.compositesb.2020.108123] |
| 15. Yao Yuyuan, Guo Qinglong, Cao Yue, Qiu Yangmin, Tan Renxiang, Yu Zhou, Zhou Yuxin, Lu Na. (2018) Artemisinin derivatives inactivate cancer-associated fibroblasts through suppressing TGF-β signaling in breast cancer. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 37 (1): (1-14). [PMID:30477536] [10.1186/s13046-018-0960-7] |
| 16. Shoubing Wang, Ziran Xu. (2016) Effects of Dihydroartemisinin and Artemether on the Growth, Chlorophyll Fluorescence, and Extracellular Alkaline Phosphatase Activity of the Cyanobacterium Microcystis aeruginosa. PLoS One, 11 (10): (e0164842). [PMID:27755566] [10.1371/journal.pone.0164842] |
| 17. Wei Wei, Xiaobing Ren, Fan Yi, Xuhui Zhang, Jiali Hou, Zhenxing Zhang, Liqian Yuan, Li Li, Qi Gao. (2025) Innovative Plant Exosome Delivery System for Enhancing Antiaging Potency on Skin. ACS Applied Bio Materials, [PMID:39992279] [10.1021/acsabm.4c01691] |